cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection [Vyxeos]
RxNorm concept 1942748, branded drug (sbd). Prescribable name: Vyxeos 44 MG / 100 MG Liposome Injection.
- RxCUI
- 1942748
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1942748 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Vyxeos 44 MG / 100 MG Liposome Injection; ara-C liposome 100 MG / DAUNOrubicin Liposomal 44 MG Injection [Vyxeos]; ara-C liposome 100 MG / Daunorubicin Liposomal 44 MG Injection [Vyxeos]; cytarabine liposome 100 MG / DAUNOrubicin liposomal 44 MG Injection [Vyxeos]
Related concepts
- cytarabine liposome 100 MG (SCDC, consists of)
- daunorubicin liposomal 44 MG (SCDC, consists of)
- cytarabine liposome 100 MG / daunorubicin liposomal 44 MG [Vyxeos] (SBDC, consists of)
- Injection (DF, has dose form)
- Vyxeos (BN, has ingredient)
- cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1942748 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1942748 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1942748. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.